Background Venous thromboembolism (VTE)(pulmonary embolism [PE] or deep venous
thrombosis [DVT]) is common during acute COVID-19. Long-term excess risk has not yet …

Coronavirus disease 2019 (COVID-19) may have a wide spectrum of clinical presentations,
leading in some cases to a critical condition with poor long-term outcomes and residual …

Background Emerging clinical evidence has shown that patients with the novel coronavirus
disease-2019 (COVID-19) have complications that include venous thromboembolism (VTE) …

Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …

Objective We have summarized the incidence, anticoagulation panels, laboratory
characteristics, and mortality of venous thromboembolism (VTE) in hospitalized patients with …

Previous studies that assessed risk factors for venous thromboembolism (VTE) in COVID-19
patients have shown inconsistent results. Our aim was to investigate VTE predictors by both …

Background Few data are available on the rate and characteristics of thromboembolic
complications in hospitalized patients with COVID-19. Methods We studied consecutive …

Background. Coronavirus disease 2019 (COVID‐19) can result in profound changes in
blood coagulation. The aim of the study was to determine the incidence and predictors of …

Background Coagulopathy is a common abnormality in patients with COVID‐19. However,
the exact incidence of venous thromboembolic event is unknown in anticoagulated, severe …

COVID-19 is associated with a variety of clinical complications including coagulopathy,
which frequently results in venous thromboembolism (VTE). Retrospective analyses …